262 related articles for article (PubMed ID: 21933972)
1. β-Blockers and survival among Danish patients with malignant melanoma: a population-based cohort study.
Lemeshow S; Sørensen HT; Phillips G; Yang EV; Antonsen S; Riis AH; Lesinski GB; Jackson R; Glaser R
Cancer Epidemiol Biomarkers Prev; 2011 Oct; 20(10):2273-9. PubMed ID: 21933972
[TBL] [Abstract][Full Text] [Related]
2. β-Blocker use and all-cause mortality of melanoma patients: results from a population-based Dutch cohort study.
Livingstone E; Hollestein LM; van Herk-Sukel MP; van de Poll-Franse L; Nijsten T; Schadendorf D; de Vries E
Eur J Cancer; 2013 Dec; 49(18):3863-71. PubMed ID: 23942335
[TBL] [Abstract][Full Text] [Related]
3. Beta-blocker usage after malignant melanoma diagnosis and survival: a population-based nested case-control study.
McCourt C; Coleman HG; Murray LJ; Cantwell MM; Dolan O; Powe DG; Cardwell CR
Br J Dermatol; 2014 Apr; 170(4):930-8. PubMed ID: 24593055
[TBL] [Abstract][Full Text] [Related]
4. Use of ß-blockers and mortality following ovarian cancer diagnosis: a population-based cohort study.
Johannesdottir SA; Schmidt M; Phillips G; Glaser R; Yang EV; Blumenfeld M; Lemeshow S
BMC Cancer; 2013 Feb; 13():85. PubMed ID: 23433478
[TBL] [Abstract][Full Text] [Related]
5. β-Blocker use and reduced disease progression in patients with thick melanoma: 8 years of follow-up.
De Giorgi V; Grazzini M; Benemei S; Marchionni N; Geppetti P; Gandini S
Melanoma Res; 2017 Jun; 27(3):268-270. PubMed ID: 28346289
[TBL] [Abstract][Full Text] [Related]
6. Survival of Danish cancer patients 1943-1987. Malignant melanoma of the skin.
Osterlind A; Kjems E
APMIS Suppl; 1993; 33():149-55. PubMed ID: 8512737
[TBL] [Abstract][Full Text] [Related]
7. Prognostic and predictive value of β-blockers in the EORTC 1325/KEYNOTE-054 phase III trial of pembrolizumab versus placebo in resected high-risk stage III melanoma.
Kennedy OJ; Kicinski M; Valpione S; Gandini S; Suciu S; Blank CU; Long GV; Atkinson VG; Dalle S; Haydon AM; Meshcheryakov A; Khattak A; Carlino MS; Sandhu S; Larkin J; Puig S; Ascierto PA; Rutkowski P; Schadendorf D; Koornstra R; Hernandez-Aya L; Di Giacomo AM; van den Eertwegh AJM; Grob JJ; Gutzmer R; Jamal R; van Akkooi ACJ; Robert C; Eggermont AMM; Lorigan P; Mandala M
Eur J Cancer; 2022 Apr; 165():97-112. PubMed ID: 35220182
[TBL] [Abstract][Full Text] [Related]
8. Treatment with β-blockers and reduced disease progression in patients with thick melanoma.
De Giorgi V; Grazzini M; Gandini S; Benemei S; Lotti T; Marchionni N; Geppetti P
Arch Intern Med; 2011 Apr; 171(8):779-81. PubMed ID: 21518948
[TBL] [Abstract][Full Text] [Related]
9. Trends in the survival of patients diagnosed with malignant melanoma of the skin in the Nordic countries 1964-2003 followed up to the end of 2006.
Tryggvadóttir L; Gislum M; Hakulinen T; Klint A; Engholm G; Storm HH; Bray F
Acta Oncol; 2010 Jun; 49(5):665-72. PubMed ID: 20491525
[TBL] [Abstract][Full Text] [Related]
10. Localized melanoma in older patients, the impact of increasing age and comorbid medical conditions.
Rees MJ; Liao H; Spillane J; Speakman D; McCormack C; Donahoe S; Pohl M; Webb A; Gyorki D; Henderson MA
Eur J Surg Oncol; 2016 Sep; 42(9):1359-66. PubMed ID: 26899940
[TBL] [Abstract][Full Text] [Related]
11. Impact of preadmission treatment with calcium channel blockers or beta blockers on short-term mortality after stroke: a nationwide cohort study.
Sundbøll J; Schmidt M; Horváth-Puhó E; Christiansen CF; Pedersen L; Bøtker HE; Sørensen HT
BMC Neurol; 2015 Mar; 15():24. PubMed ID: 25884780
[TBL] [Abstract][Full Text] [Related]
12. Effect of β-blockers and other antihypertensive drugs on the risk of melanoma recurrence and death.
De Giorgi V; Gandini S; Grazzini M; Benemei S; Marchionni N; Geppetti P
Mayo Clin Proc; 2013 Nov; 88(11):1196-203. PubMed ID: 24182700
[TBL] [Abstract][Full Text] [Related]
13. Beta-Blockers for Exams Identify Students at High Risk of Psychiatric Morbidity.
Butt JH; Dalsgaard S; Torp-Pedersen C; Køber L; Gislason GH; Kruuse C; Fosbøl EL
J Child Adolesc Psychopharmacol; 2017 Apr; 27(3):266-273. PubMed ID: 27782771
[TBL] [Abstract][Full Text] [Related]
14. Trends in melanoma in the elderly in Denmark, 1980-2012.
Hoejberg L; Gad D; Gyldenkerne N; Bastholt L;
Acta Oncol; 2016; 55 Suppl 1():52-8. PubMed ID: 26785326
[TBL] [Abstract][Full Text] [Related]
15. Social inequality and incidence of and survival from malignant melanoma in a population-based study in Denmark, 1994-2003.
Birch-Johansen F; Hvilsom G; Kjaer T; Storm H
Eur J Cancer; 2008 Sep; 44(14):2043-9. PubMed ID: 18664405
[TBL] [Abstract][Full Text] [Related]
16. Association of β-blocker therapy with risks of adverse cardiovascular events and deaths in patients with ischemic heart disease undergoing noncardiac surgery: a Danish nationwide cohort study.
Andersson C; Mérie C; Jørgensen M; Gislason GH; Torp-Pedersen C; Overgaard C; Køber L; Jensen PF; Hlatky MA
JAMA Intern Med; 2014 Mar; 174(3):336-44. PubMed ID: 24247428
[TBL] [Abstract][Full Text] [Related]
17. The impact of comorbidity and stage on prognosis of Danish melanoma patients, 1987-2009: a registry-based cohort study.
Grann AF; Frøslev T; Olesen AB; Schmidt H; Lash TL
Br J Cancer; 2013 Jul; 109(1):265-71. PubMed ID: 23681188
[TBL] [Abstract][Full Text] [Related]
18. Development of prognostic factors and survival in cutaneous melanoma over 25 years: An analysis of the Central Malignant Melanoma Registry of the German Dermatological Society.
Buettner PG; Leiter U; Eigentler TK; Garbe C
Cancer; 2005 Feb; 103(3):616-24. PubMed ID: 15630700
[TBL] [Abstract][Full Text] [Related]
19. Comparison of the clinical outcome of different beta-blockers in heart failure patients: a retrospective nationwide cohort study.
Bølling R; Scheller NM; Køber L; Poulsen HE; Gislason GH; Torp-Pedersen C
Eur J Heart Fail; 2014 Jun; 16(6):678-84. PubMed ID: 24706485
[TBL] [Abstract][Full Text] [Related]
20. The effects of beta-blockers on morbidity and mortality in a population-based cohort of 11,942 elderly patients with heart failure.
Sin DD; McAlister FA
Am J Med; 2002 Dec; 113(8):650-6. PubMed ID: 12505115
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]